Skip to main content

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 26 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

IMCD to acquire Merit Solution to strengthen its offering to the advanced materials and compounding industry in Thailand

Rotterdam, the Netherlands (29 June 2026) – IMCD N.V. (“IMCD” or “Company”), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces it has signed an agreement to acquire 100% of the shares in Merit Solution Co., Ltd (“Merit Solution”), a distributor of additives serving the plastics and compounding industry in Thailand. Merit Solution serves a diverse range of applications, including plastics, construction, and adhesives. Merit Solution will bring in an established team of 24 employees and is operated from its offices and laboratory in Bangkok. The company generated revenues of approximately THB 406 million (~EUR 10.7 million) in 2025. Pichit Pornthanalert, Managing Director, IMCD Thailand, commented, “The acquisition will strengthen IMCD’s...

Continue reading

Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline

Acquisition adds navtemadlin, a late-stage rare blood cancer asset in Phase III. This hemato-oncology program in myelofibrosis expands Ipsen’s growing Oncology portfolio Navtemadlin, an oral MDM2 inhibitor, has the potential, through disease modifying activity, to transform suboptimal responses to standard of care ruxolitinib into clinically meaningful responses in patients with myelofibrosis Top-line data from the ongoing Phase III registrational trial POIESIS is expected in 2027PARIS, FRANCE AND REDWOOD CITY, U.S., 29 JUNE 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) and Kartos Therapeutics, announced today they have entered into a definitive merger agreement under which Ipsen has agreed to acquire Kartos Therapeutics. The acquisition adds navtemadlin, an investigational MDM2 inhibitor designed to restore the natural tumor-suppressing...

Continue reading

WISeKey International Holding Ltd Signs Merger Agreement to Redomicile to the British Virgin Islands

WISeKey International Holding Ltd Signs Merger Agreement to Redomicile to the British Virgin Islands Zug, Switzerland, June 29, 2026 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding AG (“WISeKey”) (SIX: WIHN; Nasdaq: WKEY) today announced that it has signed a merger agreement with WISeKey International Corp., a British Virgin Islands company and wholly owned subsidiary of WISeKey (“WISeKey BVI”), to effect WISeKey’s proposed redomiciliation from Switzerland to the British Virgin Islands. Under the proposed transaction, WISeKey would merge with and into WISeKey BVI, with WISeKey BVI surviving the merger as the publicly traded parent company of the WISeKey group and successor to WISeKey. Following completion of the redomiciliation, WISeKey BVI is expected to have its ordinary shares directly...

Continue reading

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination BURLINGTON, Mass., June 26, 2026 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued the following statement in response to an announcement made by London-listed biotechnology company Scancell Holdings plc (“Scancell”). The Neuphoria Board notes the announcement made by Scancell earlier today about a possible combination with Neuphoria. The Scancell announcement was made following speculation in the UK press and in compliance with UK regulations. The Board can confirm that it is in discussions with Scancell about the...

Continue reading

Award-Winning Designer Uses ‘Small Business Activism’ to Challenge ICE Actions on Critical Podcast Feature

Founder of Third Coast Pillows takes ‘Pillow Talk’ to a new level on Emmy-winner John Carlos Frey’s investigative program, ‘The Raid,’ following a Gold-winning protest advertisement. Gurnee, IL, June 26, 2026 (GLOBE NEWSWIRE) — Third Coast Pillows, an artisanal home decor brand rooted in intentional design, is experiencing a massive wave of global attention following a featured appearance on the popular investigative podcast, The Raid. Hosted by six-time Emmy Award-winning journalist John Carlos Frey, the recently aired episode, “Art as Protest: Small Business Owner Confronts Mass Deportation,” shines a spotlight on the company’s bold “Small Business Activism” and its stance against recent Immigration and Customs Enforcement (ICE) enforcement actions in Minnesota. The national...

Continue reading

Eldorado Completes Acquisition of Vantage Drilling International Ltd., Creating a Scaleable Offshore Drilling Platform with Enhanced Capabilities

Dubai, June 26, 2026 (GLOBE NEWSWIRE) — Eldorado Drilling Limited (“Eldorado”) and Vantage Drilling International Ltd. (“Vantage”) today announced the completion of Eldorado’s acquisition of Vantage by merger, pursuant to which an indirect subsidiary of Eldorado merged with and into Vantage, with Vantage surviving as an indirect subsidiary of Eldorado as of 3.00 p.m. Bermuda time on June 26, 2026 (the “Closing”). Strategic and Operational Summary The combination brings together Eldorado’s Atlantic Zonda with Vantage’s asset base, strong operating capabilities, global footprint, and proven track record managing high‑specification drilling assets under long‑term operating and management arrangements, putting the combined enterprise in a position to deliver efficient, safe, and reliable services to a diversified customer base. The...

Continue reading

Sienna Completes Acquisition in Greater Ottawa Area

MARKHAM, Ontario, June 26, 2026 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) announced today that it has completed its previously disclosed acquisition of Rockland Manor, a 160-suite retirement residence in Rockland, Ontario, located within the Greater Ottawa Area. The gross purchase price for the property was approximately $41.0 million, or $256,000 per suite, with an initial Investment Yield of approximately 6.0%. Built in 2015, the property is approximately 98% occupied and offers services ranging from independent living to memory care. The acquisition was financed through available cash on hand. “Given Sienna’s growing presence in the region, we expect the addition of Rockland Manor to support meaningful synergies as we continue to scale our portfolio in Eastern...

Continue reading

Standard Dental Labs Inc. Signs Letter of Intent to Acquire Additional Dental Laboratory in the Tampa Bay Region

ORLANDO, Fla., June 26, 2026 (GLOBE NEWSWIRE) — Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”), a rapidly growing dental laboratory consolidator focused on the Florida market, today announced that it has executed a non-binding Letter of Intent (“LOI”) to acquire another established dental laboratory located in the Tampa Bay region. The identity of the laboratory and specific details regarding its operations remain confidential pursuant to the terms of the Letter of Intent and a mutual confidentiality agreement executed by both parties. The transaction remains subject to customary due diligence, negotiation of definitive agreements, and satisfaction of customary closing conditions. There can be no assurance that a definitive acquisition agreement will be executed or that the...

Continue reading

Everlert, Inc. (OTC: EVLI), Operating as American Gold & Copper Inc., Signs Memorandum of Understanding for Proposed Acquisition of the Rimrock Copper-Gold Project in Nevada

Proposed Acquisition Represents an Important Step in the Company’s Strategy to Build a U.S.-Focused Portfolio of Copper and Precious Metals Assets SOUTHLAKE, Texas, June 26, 2026 (GLOBE NEWSWIRE) — Everlert, Inc. (OTC: EVLI) (“Everlert” or the “Company”), operating under the recently adopted legal name American Gold & Copper Inc., announced that it has executed a Memorandum of Understanding (“MOU”) with Rimrock Exploration Partners, LLC (“Rimrock”) providing the framework under which American Gold & Copper would acquire a 100% interest in the Rimrock Copper-Gold Project located in Lander County, Nevada. The MOU establishes the principal terms under which the parties intend to negotiate a Definitive Acquisition Agreement over the next ninety (90) days, subject to customary technical, legal, environmental, financial, and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.